Machine learning predictions based on historical earnings data and price patterns
1-Day Prediction
+0.45%
$228.21
100% positive prob.
5-Day Prediction
+2.75%
$233.43
100% positive prob.
20-Day Prediction
+5.62%
$239.94
95% positive prob.
SEC 8-K filings with transcript text
Feb 5, 2026 · 100% conf.
1D
+0.45%
$228.21
Act: -0.38%
5D
+2.75%
$233.43
Act: -5.33%
20D
+5.62%
$239.94
Act: -3.90%
cah-202602050000721371false00007213712026-02-052026-02-05
Washington, D.C. 20549
Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2026
Cardinal Health, Inc. (Exact name of registrant as specified in its charter)
Ohio1-1137331-0958666 (State or other jurisdiction of incorporation)(Commission File Number)
(IRS Employer Identification No.)
7000 Cardinal Place, Dublin, Ohio 43017 (614) 757-5000 (Registrant’s telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common shares (without par value)CAHNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. p
Item 2.02: Results of Operations and Financial Condition On February 5, 2026, Cardinal Health, Inc. (the "Company") issued a news release announcing its results for the quarter ended December 31, 2025. A copy of the news release is included as Exhibit 99.1 to this report.
Item 7.01: Regulation FD Disclosure During a webcast scheduled to be held at 8:30 a.m. Eastern time on February 5, 2026, the Company's Chief Executive Officer and Chief Financial Officer will discuss the Company's results for the quarter ended December 31, 2025 and outlook for the fiscal year ending June 30, 2026. The slide presentation for the webcast will be available on the Investors page at ir.cardinalhealth.com. An audio replay of the webcast also will be available on the Investors page at ir.cardinalhealth.com.
Item 9.01: Financial Statements and Exhibits (d) Exhibits
Exhibit NumberExhibit Description 99.1News release issued by the Company on February 5, 2026 announcing second-quarter results.
2
Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Cardinal Health, Inc. (Registrant)
Date:February 5, 2026By:/s/ AARON E. ALT Aaron E. Alt Chief Financial Officer
3
Oct 30, 2025
cah-202510300000721371false00007213712025-10-302025-10-30
Washington, D.C. 20549
Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2025
Cardinal Health, Inc. (Exact name of registrant as specified in its charter)
Ohio1-1137331-0958666 (State or other jurisdiction of incorporation)(Commission File Number)
(IRS Employer Identification No.)
7000 Cardinal Place, Dublin, Ohio 43017 (614) 757-5000 (Registrant’s telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common shares (without par value)CAHNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. p
Item 2.02: Results of Operations and Financial Condition On October 30, 2025, Cardinal Health, Inc. (the "Company") issued a news release announcing its results for the quarter ended September 30, 2025. A copy of the news release is included as Exhibit 99.1 to this report.
Item 7.01: Regulation FD Disclosure During a webcast scheduled to be held at 8:30 a.m. Eastern time on October 30, 2025, the Company's Chief Executive Officer and Chief Financial Officer will discuss the Company's results for the quarter ended September 30, 2025 and outlook for the fiscal year ending June 30, 2026. The slide presentation for the webcast will be available on the Investors page at ir.cardinalhealth.com. An audio replay of the webcast also will be available on the Investors page at ir.cardinalhealth.com.
Item 9.01: Financial Statements and Exhibits (d) Exhibits
Exhibit NumberExhibit Description 99.1News release issued by the Company on October 30, 2025 announcing first-quarter results.
2
Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Cardinal Health, Inc. (Registrant)
Date:October 30, 2025By:/s/ AARON E. ALT Aaron E. Alt Chief Financial Officer
3
Aug 12, 2025
cah-202508120000721371false00007213712025-08-122025-08-12
Washington, D.C. 20549
Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2025
Cardinal Health, Inc. (Exact name of registrant as specified in its charter)
Ohio1-1137331-0958666 (State or other jurisdiction of incorporation)(Commission File Number)
(IRS Employer Identification No.)
7000 Cardinal Place, Dublin, Ohio 43017 (614) 757-5000 (Registrant’s telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common shares (without par value)CAHNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. p
Item 2.02: Results of Operations and Financial Condition On August 12, 2025, Cardinal Health, Inc. (the "Company") issued a news release announcing its results for the quarter and fiscal year ended June 30, 2025. A copy of the news release is included as Exhibit 99.1 to this report.
Item 7.01: Regulation FD Disclosure During a webcast scheduled to be held at 8:30 a.m. Eastern time on August 12, 2025, the Company's Chief Executive Officer and Chief Financial Officer will discuss the Company's results for the quarter and fiscal year ended June 30, 2025 and outlook for the fiscal year ending June 30, 2026. The slide presentation for the webcast will be available on the Investors page at ir.cardinalhealth.com. An audio replay of the webcast also will be available on the Investors page at ir.cardinalhealth.com. The Company also issued a news release on August 12, 2025, announcing that its multi-specialty management services organization, The Specialty Alliance, has entered into a definitive agreement to acquire Solaris Health. This news release is being furnished as Exhibit 99.2 to this Form 8-K.
Item 9.01: Financial Statements and Exhibits (d) Exhibits
Exhibit NumberExhibit Description 99.1News release issued by the Company on August 12, 2025 announcing fourth-quarter and year-end results.
99.2News release issued by the Company on August 12, 2025 announcing the entry into an agreement to acquire of Solaris Health
2
Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Cardinal Health, Inc. (Registrant)
Date:August 12, 2025By:/s/ AARON E. ALT Aaron E. Alt Chief Financial Officer
3
This page provides Cardinal Health Inc. (CAH) earnings call transcripts from SEC 8-K filings along with AI-powered predictions for post-earnings price movements. Our machine learning models analyze historical earnings data, pre-earnings price patterns, volume changes, and volatility to predict 1-day, 5-day, and 20-day returns after each earnings release.
Earnings transcripts are sourced directly from SEC EDGAR filings. Predictions are generated using gradient boosting models trained on CAH's historical earnings reactions. All predicted returns are shown as percentages, and predicted prices are calculated from the closing price at the time of prediction. Past performance does not guarantee future results.